PCOS and insulin resistance are metabolically linked — up to 70% of women with PCOS have insulin resistance, and it drives the weight gain, irregular cycles, and androgen excess that define the condition. This guide covers how a doctor treats both together, from the lab panel that confirms the diagnosis to the medication protocol that addresses insulin resistance at the metabolic root.
- Up to 70% of women with PCOS have insulin resistance, which drives androgen excess, irregular cycles, and weight gain.
- Fasting insulin — not just glucose — is the lab that detects insulin resistance years before glucose changes.
- Insulin resistance should be the primary treatment target, addressed before or alongside cycle-focused therapies like birth control.
- Metformin and GLP-1 medications (semaglutide, tirzepatide) are the two main pharmacologic options, chosen based on weight and metabolic severity.
- Labs should be rechecked at 12 and 24 weeks to confirm both metabolic and hormonal improvement.
- Resistance training and adequate protein intake improve insulin sensitivity independent of medication.
TL;DR
Treating PCOS and insulin resistance together requires a clinician who reads fasting insulin (not just glucose), prescribes based on the full metabolic and hormonal picture, and monitors both systems with scheduled lab rechecks. GoodLife Health's direct primary care membership covers both metabolic and hormonal management under one clinician. Verdict: PCOS with insulin resistance is a single metabolic problem with reproductive symptoms — treating it as two separate conditions fragments the care and slows the outcome.
Why this matters
PCOS is not primarily a reproductive condition. It's a metabolic disorder where insulin resistance drives ovarian androgen production, which causes irregular cycles, acne, hirsutism, and weight gain. The reproductive symptoms are downstream of the metabolic dysfunction.
This is why treating PCOS with birth control alone (to regulate cycles) without addressing insulin resistance manages a symptom while leaving the driver untouched. A doctor who treats both understands that improving insulin sensitivity often restores cycle regularity, reduces androgen symptoms, and enables weight loss — all without needing to suppress the reproductive system.
What you'll need
- A PCOS diagnosis confirmed by Rotterdam criteria (two of three: irregular cycles, clinical or biochemical hyperandrogenism, polycystic ovaries on ultrasound)
- Baseline labs: fasting glucose, fasting insulin, HbA1c, lipid panel, total and free testosterone, SHBG, DHEA-S, TSH, free T4
- A BMI and waist circumference baseline — PCOS weight gain is disproportionately visceral
- A clinician who manages both metabolic and hormonal aspects of PCOS
- A resistance training plan — women with PCOS have higher muscle loss risk during calorie restriction
- A symptom log tracking cycle regularity, acne, energy, and weight
The steps
1. Get the right labs — including fasting insulin, not just glucose
The most common diagnostic gap in PCOS is checking fasting glucose and HbA1c without checking fasting insulin. Glucose can stay normal for years while insulin climbs — insulin resistance develops before glucose dysregulation. A fasting insulin above 8-10 μIU/mL with normal glucose signals early insulin resistance. Ask for fasting insulin specifically. Common mistake: accepting a lab panel that checks glucose but not insulin — you miss the marker that matters most.
Glucose can stay normal for years while insulin climbs — insulin resistance develops before glucose dysregulation. A fasting insulin above 8-10 μIU/mL with normal glucose signals early insulin resistance.
2. Assess the full hormonal picture, not just testosterone
PCOS involves multiple hormonal axes: androgens (testosterone, DHEA-S), sex hormone binding globulin (SHBG), thyroid function, and sometimes cortisol. Low SHBG is common in PCOS and means more free (active) testosterone even if total testosterone is borderline. A clinician who reads the full panel — not just one number — can identify patterns that drive symptoms. Common mistake: treating testosterone alone without checking SHBG — the ratio matters more than the absolute value.
3. Address insulin resistance as the primary target
If fasting insulin is elevated, insulin resistance is the metabolic driver and should be the first treatment target. Options include lifestyle (protein, resistance training, low-glycemic nutrition), metformin, and increasingly GLP-1 or dual agonist medications (semaglutide, tirzepatide) for women with significant weight gain or prediabetes. A clinician should discuss all options, not default to one. Common mistake: starting hormonal contraception to regulate cycles without addressing the insulin resistance driving the irregularity.
4. Consider metformin or GLP-1 therapy based on insulin resistance severity
Metformin reduces hepatic glucose production and improves insulin sensitivity — it's been used off-label for PCOS for years. For women with significant weight gain (BMI 30+) or prediabetes, GLP-1 medications offer greater weight loss and metabolic improvement. Your clinician should discuss the differences: metformin is cheaper and has a longer track record in PCOS; GLP-1s produce more weight loss but require more monitoring. Common mistake: defaulting to metformin because it's familiar when a GLP-1 may be more appropriate for your metabolic profile.
Metformin vs. GLP-1 for PCOS
Choosing based on metabolic profile
| Factor | Metformin | GLP-1 (semaglutide, tirzepatide) |
|---|---|---|
| Cost | Cheaper | Higher cost, more monitoring |
| Track record | Longer track record in PCOS | Offers greater weight loss and metabolic improvement |
| Weight loss | Modest (2-5% on average) | More weight loss than metformin |
| Best fit | Milder insulin resistance | Significant weight gain (BMI 30+) or prediabetes |
5. Monitor androgen levels and cycle regularity alongside metabolic markers
As insulin resistance improves, ovarian androgen production often decreases — testosterone drops, SHBG rises, and cycles become more regular. Track these markers at 12-week intervals alongside fasting insulin and HbA1c. This is the clinical signal that the treatment is working at the metabolic root, not just managing symptoms. Common mistake: tracking only weight when the hormonal markers are the more meaningful measure of PCOS improvement.
6. Build a lifestyle protocol that targets insulin sensitivity
Protein at 1.2-1.6g per kg body weight, resistance training 2-3 times per week, and low-glycemic nutrition choices improve insulin sensitivity independently of medication. Muscle tissue is the primary site of insulin-mediated glucose disposal — building muscle directly improves insulin resistance. This isn't optional adjunct therapy; it's part of the treatment. Common mistake: relying on medication alone without addressing muscle mass — insulin sensitivity lives in muscle.
7. Reassess at 12 and 24 weeks with a full panel
At 12 weeks, check fasting insulin, HbA1c, and androgen levels. At 24 weeks, reassess the full panel plus weight, waist circumference, and cycle regularity. If insulin resistance has improved but symptoms persist, the protocol may need adjustment — either a medication change or a deeper look at other hormonal axes (thyroid, adrenal). Common mistake: waiting a full year to recheck labs when meaningful metabolic changes show up within 12 weeks.
Troubleshooting
Your cycles haven't regularized despite insulin improvement. Insulin resistance is the most common driver of cycle irregularity in PCOS, but not the only one. If androgens remain elevated or thyroid dysfunction is present, your clinician should investigate additional causes.
You're gaining weight despite metformin. Metformin improves insulin sensitivity but produces modest weight loss (2-5% on average). If you have significant weight gain (BMI 30+), a GLP-1 medication may be more appropriate. Discuss this with your clinician.
Your testosterone is still elevated after 6 months. If insulin resistance has been addressed and testosterone remains high, the source may be adrenal (DHEA-S) rather than ovarian. This requires a different treatment approach.
You want to get pregnant. Some PCOS treatments (hormonal contraception, certain medications) aren't compatible with pregnancy planning. Discuss family planning timing with your clinician before starting any protocol. GLP-1 medications should be discontinued at least 2 months before attempting conception.
Your doctor only prescribed birth control. Hormonal contraception manages cycle symptoms but doesn't address insulin resistance. If your doctor didn't check fasting insulin or discuss metabolic treatment, you're getting symptom management, not root-cause treatment.
Tools and resources
- How doctors diagnose insulin resistance — the labs that matter
- Tirzepatide for women with PCOS and insulin resistance — when a GLP-1 is appropriate
- Weight loss for women with PCOS: what actually works — the full protocol
- Best labs to run before starting hormone therapy — hormone panel details
- A symptom log tracking cycle regularity, acne, hirsutism, energy, and weight
What to do next
If you have PCOS and suspect insulin resistance, the first step is getting the right labs — specifically fasting insulin. Read about how doctors diagnose insulin resistance so you know what to request at your visit.
The lab that matters most in PCOS isn't testosterone — it's fasting insulin.
One last thing
FAQ
What's the connection between PCOS and insulin resistance? Insulin resistance drives ovarian androgen production in PCOS, causing the symptoms most women associate with the condition — irregular cycles, acne, hirsutism, and weight gain. Up to 70% of women with PCOS have insulin resistance. It's the metabolic root of the condition for most patients.
How does a doctor treat PCOS and insulin resistance together? By addressing insulin resistance as the primary target: lifestyle changes (protein, resistance training, low-glycemic nutrition), medication when appropriate (metformin, GLP-1s), and monitoring both metabolic markers (fasting insulin, HbA1c) and hormonal markers (testosterone, SHBG) at 12-week intervals.
Should I take metformin or a GLP-1 for PCOS? That depends on your metabolic profile. Metformin is cheaper and has a longer track record in PCOS; GLP-1 medications (semaglutide, tirzepatide) produce greater weight loss and may be more appropriate for women with significant weight gain or prediabetes. Discuss both options with your clinician.
Does treating insulin resistance help PCOS symptoms? Yes — improving insulin sensitivity often reduces ovarian androgen production, which can restore cycle regularity, reduce acne and hirsutism, and enable weight loss. The reproductive symptoms are downstream of the metabolic dysfunction.
What labs should I ask for with PCOS? Fasting glucose, fasting insulin, HbA1c, lipid panel, total and free testosterone, SHBG, DHEA-S, TSH, and free T4. The most commonly missed lab is fasting insulin — it detects insulin resistance before glucose changes.
Can PCOS be cured by treating insulin resistance? PCOS isn't curable, but treating insulin resistance can significantly improve or resolve symptoms for many women. The goal is metabolic and hormonal management, not a cure.
Is birth control enough for PCOS? Birth control manages cycle symptoms but doesn't address insulin resistance — the metabolic driver of PCOS. A treatment plan that only includes birth control is managing a symptom, not treating the root cause.
One last thing
The lab that matters most in PCOS isn't testosterone — it's fasting insulin. If your doctor checked your glucose and said it was normal, ask specifically about fasting insulin. Insulin resistance develops years before glucose changes, and catching it early changes the entire treatment trajectory.
Related guides
References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/